Background: Rapid drug desensitization (RDD) allows first-line therapies in patients with
immediate drug hypersensitivity reactions (DHR) to chemotherapeutic drugs (ChD) and …

Background Rapid drug desensitization (RDD) becomes a crucial procedure to allow
treatment continuation in patients who suffer drug hypersensitivity reactions (DHRs) to …

Opinion Statement Adverse drug reactions have increased dramatically worldwide, often
preventing the use of first-line therapies. Not infrequently, many patients presenting with …

Background Rapid drug desensitization (RDD) is used to address hypersensitivity reactions
to chemotherapeutics and monoclonal antibodies, allowing patients to be treated with …

Abstract Background Severe hypersensitivity reactions (HSRs) interfere with the
administration of necessary drugs for patients; drug desensitization can be a good …

BACKGROUND: Rapid desensitization, a procedure for graded drug administration, allows
for the safe readministration of a medication after certain types of hypersensitivity reactions …

Background: Rapid drug desensitization (RDD) induces a temporary tolerance to biologics
which induce hypersensitivity reactions (HSRs). Data are limited regarding the use of RDD …

Chemotherapies drugs and monoclonal antibodies are key components of the treatment of
cancer patients and patients with chronic inflammatory conditions to provide increase in life …

Hypersensitivity reactions to monoclonal antibodies and chemotherapy, which may vary in
severity from mild to life-threatening, can lead to their discontinuation and replacement by …

Background: Rapid drug desensitization (RDD) induces a temporary tolerance to
chemotherapeutics that induce hypersensitivity reactions (HSRs). Purpose: Our objective is …